FERTRIAN
Live / Registered — Registered (as of 18 Feb 2020)
What this means for you
Registered since 18 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79263045
- Registration number
- 5986946
- Mark type
- Stylized text
- Filed
- 16 May 2019
- Published for opposition
- 03 Dec 2019
- Registered
- 18 Feb 2020
- Attorney of record
- Merilee J. Arevalo
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
- Glaxo Group Limited, GB
- Glaxo Group Limited, Middlesex, GB
- Glaxo Group Limited, Middlesex, GB
Prosecution history
- 23 May 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Feb 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 28 Jul 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 10 Jul 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 18 Jun 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 18 Jun 2020 — FINAL DISPOSITION PROCESSED
- 18 May 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 18 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2019 — PUBLISHED FOR OPPOSITION
- 13 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Nov 2019 — REFUSAL PROCESSED BY IB
- 31 Oct 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 31 Oct 2019 — ASSIGNED TO LIE
- 26 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER